YahooOctober 5, 2026 at 11:05 AM NY22 Days Ago
HeartBeam stock soars on FDA breakthrough designation
Investing.com -- Heartbeam Inc (NASDAQ:BEAT) shares surged as much as 90% Monday after the company announced the U.S. Food and Drug Administration granted Breakthrough Device Designation for its at-home heart attack assessment tool.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
